BrandedUp in partnership with
Did you know that acne is the most common skin disease in the Philippines? It affects over 17 million people, young and old. Not only that; it can be painful and embarrassing, and can affect self-esteem, relationships, and happiness, especially in teens. Here’s more: clinical studies have found that more than 50 percent of people with facial acne also have chest, shoulder, and back acne.
Patients invest time and money in hygiene habits and treatment products just to get rid of acne. But there’s good news: overcoming acne is possible with the proper treatment, and as long as you start it early.
A safe retinoid cream to the rescue
If you’re looking for treatment, remember to get it from a board-certified dermatologist. Only they can give you safe and effective prescription options, such as the newest retinoid innovation: Trifarotene cream.
This prescription is an innovative topical single-agent retinoid cream that has been proven safe and effective for acne on the face, shoulders, and back.
Trifarotene cream contains the retinoid molecule, which helps the skin replace old cells at a faster speed. It removes old skin cells and prevents new acne from forming. Trifarotene works by specifically targeting the retinoic acid receptor gamma (RAR-y), the most prevalent receptor in the skin. By doing this, it reduces inflammation and targets the important factors that cause acne.
Trifarotene is the first new retinoid molecule to receive FDA approval for treating acne in over 25 years. It offers both dermatologists and acne patients a safe and effective prescription acne medication. Even better, it heals acne not just on the face but also on the back, chest, and shoulders.
Brought to you by a leading skincare company
Galderma, a world leader in developing innovative and safe dermatologist-approved skincare solutions, brings Trifarotene to the Philippines market.
They’re certainly not new in the business. The same company also gave the world well-loved brands, such as Cetaphil, Benzac, and Restylane, among many others. With the addition of Trifarotene to its portfolio, Galderma further cements its claim as one of the most innovative dermatologist-recommended skincare-focused companies in the world today.
Trifarotene will only be prescribed by duly licensed healthcare practitioners, primarily dermatologists, and is recommended for patients 12 years and older.
Galderma, the world’s largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. Galderma is a leader in the research and development of scientifically defined and medically proven solutions for the skin. Partnering with healthcare practitioners around the world to meet the skin health needs of people throughout their lifetime, the company aims to change the way the world thinks about skin health.
For more information, please visit www.galderma.com.
* * *
Editor’s Note: This article was provided by Galderma.